Delivery Order SPE2DB22D3016-SPE2DB25FBHZ8
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Ketorolac 0.5% ophthalmic solution (5 ml). The delivery order, valued at $1,166.40, has a completion date of January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 and effective through December 31, 2025. This IDC serves...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,587.10, was awarded by the Defense Logistics Agency (DLA) for the delivery of Ketorolac 0.5% ophthalmic solution, a medication commonly used to treat eye-related pain and inflammation. The contract is a delivery order, with a firm fixed price pricing type, and has an ultimate completion date of December 13, 2024. This award is not...
- The Defense Logistics Agency awarded a $2,670 delivery order to Amerisourcebergen Drug Corporation for ketorolac ophthalmic solution. As the prime contractor, Amerisourcebergen will supply 5mL bottles of the 0.5% strength ophthalmic solution to meet DLA requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of three days from September 8 through 11, 2023. The firm fixed price contract was awarded utilizing Amerisourcebergen's position...
- The Defense Logistics Agency awarded a $38,670 delivery order to Amerisourcebergen Drug Corporation for ketorolac ophthalmic solution. As the prime contractor, Amerisourcebergen will supply 5mL bottles of the 0.5% strength ophthalmic solution to meet DLA requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period from September 6-7, 2023. The firm fixed price contract was awarded utilizing Amerisourcebergen's position on an existing...
- The Defense Logistics Agency awarded a $41,110 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketorolac ophthalmic solution. As the prime contractor, Amerisourcebergen will supply 5mL bottles of the 0.4% strength ophthalmic solution to meet DLA requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period from July 10-11, 2023. The delivery order was issued under DLA's indefinite-delivery/indefinite-quantity...
- The Defense Logistics Agency awarded a $38,670 delivery order to Amerisourcebergen Drug Corporation for ketorolac ophthalmic solution. As the prime contractor, Amerisourcebergen will supply 5mL bottles of the 0.5% strength ophthalmic solution to meet DLA requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one-day period from September 6-7, 2023. The firm fixed price contract was issued under DLA's indefinite-delivery/indefinite-quantity...
- The Defense Logistics Agency awarded a $102 delivery order to Amerisourcebergen Drug Corporation for ketorolac ophthalmic solution. As the prime contractor, Amerisourcebergen will supply 5mL bottles of the 0.4% strength ophthalmic solution to meet needs under the agency's pharmaceutical programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three-day period in early September 2023. The firm fixed price contract type provides certainty of cost to the...
- The Defense Logistics Agency awarded a $2,670 firm fixed price delivery order to Amerisourcebergen Drug Corporation for ketorolac ophthalmic solution. As the prime contractor, Amerisourcebergen will supply 5mL bottles of the 0.5% strength ophthalmic solution to meet DLA requirements. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a one day period in early September 2023. The delivery order was issued under DLA's pharmaceuticals and medical/surgical...
- The Defense Logistics Agency awarded a $102 delivery order to Amerisourcebergen Drug Corporation for ketorolac ophthalmic solution. As the prime contractor, Amerisourcebergen will supply 5mL bottles of the 0.4% strength ophthalmic solution to meet needs under the agency's pharmaceutical programs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a period of three days from September 8 through 11, 2023. The firm fixed price contract type provides...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA), which provides logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. The $6,901.75 Delivery Order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the federal government, including the Department of Defense (DoD) and Veterans Affairs (VA). The...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB25FBHZ8Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Ketorolac 0.5% ophthalmic solution in 10ml units with a ceiling value of $1,032.06. This award was made on September 11, 2025, under firm fixed pricing with an ultimate completion date of September 12, 2025. The contract utilized no set-aside designation and was competitively awarded. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the prime contractor and will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive IDC functions as a global pharmaceutical support vehicle enabling AmerisourceBergen to supply pharmaceutical products and medical supplies to support military healthcare programs worldwide. The arrangement reflects the company's established capability to fulfill federal medical procurement requirements and its critical role in supporting the Defense Health Agency and other military healthcare systems through flexible, competitively awarded contracting mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 9/11/25 |